摘要
由21号染色体三体引起的唐氏综合征(DS),以智力障碍(ID)和阿尔茨海默病(AD)的早期发病的病理改变为特点,包括海马胆碱能投射系统的退化。本篇我们确定年龄和母体的胆碱补充(MCS)对Ts65Dn小鼠海马胆碱能缺陷的影响,与6-8月龄和14-18月龄的2N小鼠作比较。Ts65Dn小鼠和二体(2N)小鼠在6-8月龄、14-18月龄被处死用于老化的研究, 从生产后的Ts65Dn 小鼠分出的Ts65Dn和2N的小鼠维持补充胆碱或胆碱-对照(从怀孕到断奶期)饮食,在14-18月龄进行检测研究MCS。在后者的研究里,用径向臂水迷宫实验(RAWM)做行为测试,并检测海马组织的胆碱乙酰转移酶(ChAT)的免疫反应性。在单独的群组里评价海马胆碱乙酰转移酶(ChAT)的免疫活性。Ts65Dn小鼠海马和齿状回胆碱乙酰转移酶(ChAT)阳性神经纤维分布显著高于2N的小鼠,不受年龄或孕期饮食的限制。同样地, 与2N的小鼠相比,Ts65Dn小鼠的胆碱乙酰转移酶(ChAT)活性显著升高,不受年龄或孕期饮食的限制。随着年龄的增长,2N小鼠的海马胆碱能神经分布显着增加,而不是Ts65Dn小鼠。胆碱乙酰转移酶(ChAT)强度与未补充胆碱的2N和Ts65Dn小鼠的空间记忆能力呈负相关,但与母体胆碱补充的2N小鼠正相关。因母体胆碱的补充而增加的神经分布显示了海马功能的改善,,可以利用此转化途径用于将来对人类的唐氏综合症的治疗。
关键词: Aging
Current Alzheimer Research
Title:Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome
Volume: 13 Issue: 1
Author(s): Christy M. Kelley, Jessica A. Ash, Brian E. Powers, Ramon Velazquez, Melissa J. Alldred, Milos D. Ikonomovic and Stephen D. Ginsberg, Barbara J. Strupp and Elliott J. Mufson
Affiliation:
关键词: Aging
摘要: Down syndrome (DS), caused by trisomy of chromosome 21, is marked by intellectual disability (ID) and early onset of Alzheimer’s disease (AD) neuropathology including hippocampal cholinergic projection system degeneration. Here we determined the effects of age and maternal choline supplementation (MCS) on hippocampal cholinergic deficits in Ts65Dn mice compared to 2N mice sacrificed at 6-8 and 14-18 months of age. Ts65Dn mice and disomic (2N) littermates sacrificed at ages 6-8 and 14-18 mos were used for an aging study and Ts65Dn and 2N mice derived from Ts65Dn dams were maintained on either a choline-supplemented or a choline-controlled diet (conception to weaning) and examined at 14-18 mos for MCS studies. In the latter, mice were behaviorally tested on the radial arm Morris water maze (RAWM) and hippocampal tissue was examined for intensity of choline acetyltransferase (ChAT) immunoreactivity. Hippocampal ChAT activity was evaluated in a separate cohort. ChAT-positive fiber innervation was significantly higher in the hippocampus and dentate gyrus in Ts65Dn mice compared with 2N mice, independent of age or maternal diet. Similarly, hippocampal ChAT activity was significantly elevated in Ts65Dn mice compared to 2N mice, independent of maternal diet. A significant increase with age was seen in hippocampal cholinergic innervation of 2N mice, but not Ts65Dn mice. Degree of ChAT intensity correlated negatively with spatial memory ability in unsupplemented 2N and Ts65Dn mice, but positively in MCS 2N mice. The increased innervation produced by MCS appears to improve hippocampal function, making this a therapy that may be exploited for future translational approaches in human DS.
Export Options
About this article
Cite this article as:
Christy M. Kelley, Jessica A. Ash, Brian E. Powers, Ramon Velazquez, Melissa J. Alldred, Milos D. Ikonomovic and Stephen D. Ginsberg, Barbara J. Strupp and Elliott J. Mufson , Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome, Current Alzheimer Research 2016; 13 (1) . https://dx.doi.org/10.2174/1567205012666150921100515
DOI https://dx.doi.org/10.2174/1567205012666150921100515 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!
Current Pharmaceutical Biotechnology Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BBInduced Neuroprotection
Current Alzheimer Research MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews CD44 and EpCAM: Cancer-Initiating Cell Markers
Current Molecular Medicine Signaling Mechanism(S) of Reactive Oxygen Species in Epithelial-Mesenchymal Transition Reminiscent of Cancer Stem Cells in Tumor Progression
Current Stem Cell Research & Therapy Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics
Current Pharmaceutical Design Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery
Current Topics in Medicinal Chemistry Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Current Medicinal Chemistry Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases
Current Topics in Medicinal Chemistry Screening Neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation Induced PC12 Injury Models: A Review
Current Psychopharmacology RNAi Applications in Therapy Development for Neurodegenerative Disease
Current Pharmaceutical Design Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Extranuclear Localization of SIRT1 and PGC-1α: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction
Current Molecular Medicine Metal Based Frameworks for Drug Delivery Systems
Current Topics in Medicinal Chemistry Chest Pain in Children
Current Pediatric Reviews Saponins in Tumor Therapy
Mini-Reviews in Medicinal Chemistry Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders
Current Pharmacogenomics and Personalized Medicine Combination of DC Vaccine and Conventional Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
Current Pharmaceutical Design Green Approaches for Cancers Management: An Effective Tool for Health Care
Anti-Cancer Agents in Medicinal Chemistry